Patients Sponsored Unlocking the Power of Storytelling in Medical Publications In this era of accelerating information, it is more critical than ever to be clear and engaging in medical publications – and that increasingly involves the skill of scientific storytelling
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.